Cargando…
Malondialdehyde-Acetaldehyde Modified (MAA) Proteins Differentially Effect the Inflammatory Response in Macrophage, Endothelial Cells and Animal Models of Cardiovascular Disease
Chronic inflammation plays a critical role in the pathogenesis of atherosclerosis. Currently, the mechanism(s) by which inflammation contributes to this disease are not entirely understood. Inflammation is known to induce oxidative stress, which can lead to lipid peroxidation. Lipid peroxidation can...
Autores principales: | Duryee, Michael J., Clemens, Dahn L., Opperman, Patrick J., Thiele, Geoffrey M., Duryee, Logan M., Garvin, Robert P., Anderson, Daniel R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657968/ https://www.ncbi.nlm.nih.gov/pubmed/34884754 http://dx.doi.org/10.3390/ijms222312948 |
Ejemplares similares
-
Malondialdehyde-acetaldehyde (MAA) modified proteins induce pro-inflammatory and pro-fibrotic responses by liver endothelial cells
por: Thiele, Geoffrey M, et al.
Publicado: (2004) -
Unique Antibody Responses to Malondialdehyde-Acetaldehyde (MAA)-Protein Adducts Predict Coronary Artery Disease
por: Anderson, Daniel R., et al.
Publicado: (2014) -
Direct antioxidant properties of methotrexate: Inhibition of malondialdehyde-acetaldehyde-protein adduct formation and superoxide scavenging
por: Zimmerman, Matthew C., et al.
Publicado: (2017) -
Citrullinated and malondialdehyde-acetaldehyde modified fibrinogen activates macrophages and promotes an aggressive synovial fibroblast phenotype in patients with rheumatoid arthritis
por: Aripova, Nozima, et al.
Publicado: (2023) -
Serum anti-malondialdehyde-acetaldehyde IgA antibody concentration improves prediction of coronary atherosclerosis beyond traditional risk factors in patients with rheumatoid arthritis
por: Lomzenski, Hannah E., et al.
Publicado: (2022)